Bulletin: QRISK-3/SCORE2 Cardiovascular health Calculator also predicts Cancer Risk

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Healthcare practitioners may soon be able to use tweaked standard cardiovascular prediction tools to identify patients at risk of various cancers.

The post Bulletin: QRISK-3/SCORE2 Cardiovascular health Calculator also predicts Cancer Risk appeared first on Medical News Bulletin.

How Mental Health Professionals Determine the Right Level of Care

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

The most important question in behavioral health isn’t whether treatment is needed. It’s determining the level of clinical support most likely to produce meaningful improvement. Appropriate treatment isn’t mechanically prescribed after receiving an analysis of mental capability. Psychiatric competency specialists investigate symptom severity, day-by-day functioning, protection issues, pretreatment response, medical information, and modern medical proof […]

The post How Mental Health Professionals Determine the Right Level of Care appeared first on Medical News Bulletin.

Understanding the Different Levels of Mental Health Care

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Two people may receive the same mental health diagnosis yet benefit from very different treatment plans based on their symptoms, daily functioning, treatment history, and overall clinical needs. That’s why mental health professionals don’t endorse care based totally on a diagnosis by itself. A comprehensive evaluation considers how symptoms affect daily life, whether prior treatment […]

The post Understanding the Different Levels of Mental Health Care appeared first on Medical News Bulletin.

FDA approves Jideytro for previously treated ROS1-positive NSCLC

The FDA has approved zidesamtinib for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer.
Zidesamtinib (Jideytro, GSK) is designed to provide highly selective coverage of ROS1 mutations and improved blood-brain-barrier penetration for patients previously treated with a ROS1 kinase inhibitor.
The FDA based its decision on results from the global, single-arm ARROS-1 phase 1/phase 2 clinical trial, which showed “durable and meaningful responses” to treatment with zidesamtinib in ROS1-positive NSCLC, according to a GSK press release.
“Despite advances in treatment,

Life expectancy rising, but additional years spent in poor health

More people globally are living longer, but many of those extra years are spent experiencing disability and diseases, according to a new report in Lancet Public Health.
“The central finding is that we are adding years to life faster than we are adding health to those years,” Simon I. Hays, DPhil, DSc, FMedSci, director of research strategy at the Institute for Health Metrics and Evaluation (IHME), told Healio.
Several recent IHME reports have indicated encouraging jumps in life expectancy over the last couple years, with a 2025 study showing that life expectancy returned to prepandemic rates in

Senate committee delays vote on CDC director nomination

The Senate’s Health, Education, Labor and Pensions Committee delayed a scheduled vote Thursday on the nomination of Erica Schwartz, MD, JD, MPH, to be the next CDC director.
The vote was scheduled to occur off the Senate floor but was postponed because of “attendance issues,” according to the office of Republican HELP Committee Chair Bill Cassidy, MD, of Louisiana.
Republicans control the Senate and have a one-member majority on each committee. Politico reported that Sen. Lisa Murkowski, R-Alaska, was absent due to a family emergency, which means at least one non-Republican would have had to

Can the ‘bucket of doom’ prevent mosquito-borne diseases?

Experts are touting a new DIY weapon in the war against mosquito-borne diseases.
The “bucket of doom” is an eco-friendly mosquito trap that has trended on social media this summer.
“I love the name, bucket of doom,” Thomas A. Moore, MD, FACP, FIDSA, said during a recent call with the media set up by the Infectious Diseases Society of America. “Come on, it’s great marketing.”
Moore and other ID experts said the bucket could be a gamechanger in bypassing pesticides that kill pollinators such as bees and butterflies while preventing mosquito bites — and possibly disease.
“We use them all the time

Socioeconomic status tied to congenital heart disease death

Survival for adults with congenital heart disease improved over the past 30 years, but those living in states with lower median household income and more uninsured people had higher rates of death and disability, researchers reported.
Household income and insured status may serve as significant indicators for areas where residents with congenital heart disease may experience disparate morbidity and mortality, according to data published in the Journal of the American Heart Association.
“While having health insurance does matter, it does not explain the differences we found in terms of how long

Most young adults with advanced cancer do not get palliative care

More than 80% of young adults with advanced cancer do not receive guideline-recommended palliative care along with systemic treatment despite utilization doubling between 2010 and 2023.
Patients with lung, gastric and kidney cancers received concurrent palliative care at the highest rates, whereas those with Hodgkin and non-Hodgkin lymphoma and poor-prognosis brain tumors had the lowest usage.
“Palliative care should be integrated earlier and more consistently as part of routine cancer care for young adults with advanced disease,” Kewei S. Shi, MPH, associate scientist and health services

Lifestyle changes with GLP-1s may improve bone health

PARK CITY, Utah — When used for weight loss, previously published literature has shown GLP-1s may lead to bone resorption and muscle loss. However, a presenter here said the addition of strength training may mitigate these adverse outcomes.
“In the diabetes group, the goal of [GLP-1s] is not necessarily weight loss. It is glycemic control and the doses are also typically lower,” Jocelyn Wittstein, MD, associate professor of orthopedic surgery at Duke University Medical Center, told Healio. “The weight loss doses are usually higher. They are losing weight and then within